Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease

被引:29
作者
Reed, Berenice Y. [1 ]
Masoumi, Amirali [1 ]
Elhassan, Elwaleed [1 ]
McFann, Kim [1 ,2 ]
Cadnapaphornchai, Melissa A. [3 ,4 ]
Maahs, David M. [3 ,5 ]
Snell-Bergeon, Janet K. [3 ,5 ]
Schrier, Robert W. [1 ]
机构
[1] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA
[2] Univ Colorado Denver, Colorado Sch Publ Hlth Biostat & Informat, Aurora, CO 80045 USA
[3] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA
[4] Childrens Hosp, Aurora, CO USA
[5] Barbara Davis Ctr Childhood Diabet, Aurora, CO USA
关键词
ADPKD; cardiovascular disease; children; kidney volume; VEGF; ANGIOTENSIN-ALDOSTERONE SYSTEM; LEFT-VENTRICULAR HYPERTROPHY; RENAL VOLUME; II INFUSION; CHILDREN; ANGIOPOIETIN-1; HYPERTENSION; FAMILY; VEGF;
D O I
10.1038/ki.2010.355
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cysts, pain, and hematuria are common presentations of autosomal dominant polycystic kidney disease (ADPKD) in children. Renal function, however, is typically preserved in these patients despite increased renal volume. Since angiogenesis has been implicated in promotion of renal cyst growth in ADPKD, we measured the serum level of various angiogenic factors and early renal structural changes and cardiovascular parameters in 71 patients with ADPKD, with a mean age of 16 years. Renal structure and left ventricular mass index were measured by magnetic resonance imaging or by echocardiogram. Renal function was assessed by creatinine clearance and urinary protein excretion. Serum growth factor levels were measured by enzyme-linked immunosorbent assay. Because of skewed distributions, the various parameters are reported as log(10). Serum log10 vascular endothelial growth factor was positively correlated with renal and cardiac structure, but negatively with creatinine clearance. Serum angiopoietin 1 levels significantly correlated with structural change in both the kidney and the heart and with urinary protein. Thus, the correlation between angiogenic growth factors with both renal and cardiac disease severity is compatible with a possible role for angiogenesis in the early progression of disease in ADPKD. Kidney International (2011) 79, 128-134; doi: 10.1038/ki.2010.355; published online 29 September 2010
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
  • [21] Caffeine intake by patients with autosomal dominant polycystic kidney disease
    Vendramini, L. C.
    Nishiura, J. L.
    Baxmann, A. C.
    Heilberg, I. P.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (09) : 834 - 840
  • [22] Optimal care of autosomal dominant polycystic kidney disease patients
    Schrier, RW
    [J]. NEPHROLOGY, 2006, 11 (02) : 124 - 130
  • [23] Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective
    Abou Heidar, Nassib
    Chehab, Omar
    Morsi, Rami Z.
    Elias, Joseph
    El Mouhayyar, Christopher
    Kanj, Amjad
    Ajam, Mustafa
    Haykal, Abdallah
    Pahuja, Mohit
    Dakik, Habib
    Levine, Diane
    Imran, Nashat
    Abidov, Aiden
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (07) : 659 - 668
  • [24] Autosomal dominant polycystic kidney disease
    Simms, Roslyn J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [25] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [26] Interpretation of Renal Volume in Autosomal Dominant Polycystic Kidney Disease and Relevant Clinical Implications
    Masoumi, Amirali
    Elhassan, Elwaleed
    Schrier, Robert W.
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2011, 5 (01) : 1 - 8
  • [27] Autosomal Dominant Polycystic Kidney Disease
    Perumareddi, Parvathi
    Trelka, Darin P.
    [J]. PRIMARY CARE, 2020, 47 (04): : 673 - 689
  • [28] Autosomal Dominant Polycystic Kidney Disease
    Suarez, Maria Lourdes Gonzalez
    Titan, Silvia
    Dahl, Neera K.
    [J]. ADVANCES IN KIDNEY DISEASE AND HEALTH, 2024, 31 (06): : 496 - 503
  • [29] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 830 - 840
  • [30] Autosomal dominant polycystic kidney disease
    Serra A.L.
    Wüthrich R.P.
    [J]. Der Nephrologe, 2007, 2 (6): : 459 - 468